The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

The stock's fall snapped a five-day winning streak.

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

UBS lowered the firm’s price target on Moderna (MRNA) to $96 from $108 and keeps a Buy rating on the shares as part of a broader note on the ...

Shares of Moderna Inc. (NASDAQ: MRNA) surged over 12% after news of the first confirmed death from the H5N1 bird flu in the ...

U.S. stock futures edge lower after a tech selloff yesterday, investors prepare for a halt to trading tomorrow for the ...